Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.
about
Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer.Clinical implications of tumor necrosis factor receptor 2 in breast cancer.Histological and immunohistochemical study of estrogen and progesterone receptors in normal human breast tissue in adult age groups vulnerable to malignancy.Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer.Machine learning approaches to decipher hormone and HER2 receptor status phenotypes in breast cancer.Canine mammary tumors as a model for human disease.
P2860
Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@ast
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@en
type
label
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@ast
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@en
prefLabel
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@ast
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@en
P2093
P2860
P50
P1433
P1476
Estrogen-Receptor, Progesteron ...... Quant™ Microarray Based Assay.
@en
P2093
B Sigal-Zafrani
H Peyro-Saint-Paul
S Carpentier
P2860
P304
P356
10.1371/JOURNAL.PONE.0146474
P407
P577
2016-02-01T00:00:00Z